Because the Intelligence Community utilizes commercial products including those that may be manufactured abroad, it could be vulnerable to threat or compromise through its supply chain. Intelligence Community Directive 731 issued by Director of National Intelligence James Clapper on December 7 establishes IC policy on “Supply Chain Risk Management.”
“Many IC mission-critical products, materials, and services come from supply chains that interface with or operate in a global marketplace. A greater understanding of the risks inherent in the IC’s participation in the global market place is crucial to safeguarding our nation’s intelligence sources, methods, and activities,” the Directive said.
“Supply chain risk management is the management of risk to the integrity, trustworthiness, and authenticity of products and services within the supply chain.”
“It addresses the activities of foreign intelligence entities … and any other adversarial attempts aimed at compromising the IC supply chain, which may include the introduction of counterfeit or malicious items into the IC supply chain,” the Directive said.
At least 40% of Medicare beneficiaries do not have a documented AHCD. In the absence of one, medical professionals may perform major and costly interventions unknowingly against a patient’s wishes.
AI has transformative potential in the public health space, but innovation driven primarily by the private sector today may be exacerbating existing disparities by training models.
With targeted policy interventions, we can efficiently and effectively support the U.S. innovation economy through the translation of breakthrough scientific research from the lab to the market.
Crowd forecasting methods offer a systematic approach to quantifying the U.S. intelligence community’s uncertainty about the future and predicting the impact of interventions, allowing decision-makers to strategize effectively and allocate resources by outlining risks and tradeoffs in a legible format.